Skip to main content

Table 2 Patient characteristics

From: Presentations of tetramethylammonium hydroxide dermal exposure and the valuable potential of diphoterine solution in decontamination: a retrospective observational study

 

Number of cases,

N = 29 (%)

Sex

 Male

24 (82.8%)

 Female

5 (17.2%)

Age (years)

 21–30

17 (58.6%)

 31–40

9 (31%)

 > 40

3 (10.3%)

Concentration of TMAH (%)

 25%

6 (20.7%)

 20% diluted

1 (3.4%)

 3%

1 (3.4%)

 2.38%

11 (37.9%)

 2.36%

1 (3.4%)

 1–3%

1 (3.4%)

 0.50%

2 (6.9%)

 N/A

6 (20.7%)

Exposed BSA(%)

 > 5%

2 (6.9%)

 5%

1 (3.4%)

 2%

2 (6.9%)

 2 ~ 1%

1 (3.4%)

 1%

5 (17.2%)

 < 1%

16 (55.2%)

 N/A

2 (6.9%)

Elapsed time to decontamination

 40 min

1 (3.4%)

 30 min

2 (6.9%)

 5 min

1 (3.4%)

 5 min–1 min

2 (6.9%)

 < 1 min

3 (10.3%)

 None

1 (3.4%)

 N/A

19 (65.5%)

Decontamination time

 30 min

3 (10.3%)

 20 min

3 (10.3%)

 20 min–15 min

1 (3.4%)

 15 min

2 (6.9%)

 None

1 (3.4%)

 N/A

19 (65.5%)

Diphoterine

 Used

5 (17.2%)

 None

24 (82.8%)